Repository logo
 

Variations in killer-cell immunoglobulin-like receptor and human leukocyte antigen genes and immunity to malaria

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Tukwasibwe, Stephen 
Nakimuli, Annettee 
Chazara, Olympe 
Jayaraman, Jyothi 

Abstract

Malaria is one of the deadliest infectious diseases in the world. Immune responses to Plasmodium falciparum malaria vary among individuals and between populations. Human genetic variation in immune system genes is likely to play a role in this heterogeneity. Natural killer (NK) cells produce inflammatory cytokines in response to malaria infection, kill intraerythrocytic Plasmodium falciparum parasites by cytolysis, and participate in the initiation and development of adaptive immune responses to plasmodial infection. These functions are modulated by interactions between killer-cell immunoglobulin-like receptors (KIR) and human leukocyte antigens (HLA). Therefore, variations in KIR and HLA genes can have a direct impact on NK cell functions. Understanding the role of KIR and HLA in immunity to malaria can help to better characterize antimalarial immune responses. In this review, we summarize the different KIR and HLA so far associated with immunity to malaria.

Description

Keywords

Genetic variation, Human Leukocyte Antigen, Innate immunity, Killer-cell immunoglobulin-like receptor, Malaria, Natural killer cells, Genetic Variation, HLA Antigens, Haplotypes, Humans, Immunity, Malaria, Plasmodium falciparum

Journal Title

Cellular & Molecular Immunology

Conference Name

Journal ISSN

1672-7681
2042-0226

Volume Title

Publisher

Springer Science and Business Media LLC

Rights

All rights reserved
Sponsorship
Wellcome Trust (200841/Z/16/Z)
Wellcome Trust (107743/Z/15/Z)
European Research Council (695551)
This work was supported through the DELTAS Africa Initiative (Grant no. 107743), that funded Stephen Tukwasibwe through PhD fellowship award, and Annettee Nakimuli through group leader award. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Science (AAS), Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa’s Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (Grant no. 107743) and the UK government. Francesco Colucci is funded by Wellcome Trust grant 200841/Z/16/Z. The project received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement No. 695551) for James Traherne and John Trowsdale. Jyothi Jayaraman is a recipient of fellowship from the Centre for Trophoblast Research.